Your browser doesn't support javascript.
loading
Development and validation of the PERCEPT-PREVENT tool to determine risk perception and attitudes towards digestive cancer screening.
Silva, João Carlos; Santos, Cristina; Dinis-Ribeiro, Mário; Libânio, Diogo.
Afiliação
  • Silva JC; Gastroenterology Department, Centro Hospitalar Vila Nova de Gaia Espinho (CHVNGE), Vila Nova de Gaia.
  • Santos C; MEDCIDS, Faculty of Medicine, University of Porto.
  • Dinis-Ribeiro M; MEDCIDS, Faculty of Medicine, University of Porto.
  • Libânio D; CINTESIS@RISE, Faculty of Medicine, University of Porto.
Eur J Gastroenterol Hepatol ; 36(1): 45-51, 2024 01 01.
Article em En | MEDLINE | ID: mdl-37994621
ABSTRACT
BACKGROUND AND

AIMS:

Colorectal cancer (CRC) screening is recommended worldwide, while gastric cancer (GC) screening may also be defendable in some settings. However, adherence rates and factors influencing participation are not well characterized. This study aimed to validate a tool to determine risk perception of CRC and GC and also of endoscopy-related complications.

METHODS:

A questionnaire in CRC risk perception based on the Health Belief Model was used. Forward/backward translation (English-Portuguese) and cultural adaptation were performed. After revision by a panel of experts, the questionnaire was adapted to target GC risk perception and perceptions towards endoscopy-related complications. The final version of the questionnaire (PERCEPT-PREVENT tool) was applied to 44 individuals, through telephonic interview, at enrolment and at intervals ≤3 weeks. Test-retest reliability and agreement were assessed.

RESULTS:

Almost perfect reliability between test and retest was obtained for CRC symptom knowledge score (ICC = 0.88), risk factor knowledge score (ICC = 0.89), and perceived severity (ICC = 0.84). At least moderate agreement between test and retest was obtained for GC symptom knowledge score (ICC = 0.94), risk factor knowledge score (ICC = 0.92), and perceived severity (ICC = 0.58). Test-retest reliability was assessed for barrier domains [faecal occult blood test ICC = 0.63; colonoscopy ICC = 0.79; upper GI endoscopy (UGIE) ICC = 0.83]. A total of 91% and 98% of participants gave the same answer in the test and retest for preferred method of CRC screening and intention to undergo UGIE for GC screening combined with a screening colonoscopy, respectively.

DISCUSSION:

PERCEPT-PREVENT is a valid and reliable tool for CRC and GC risk perception evaluation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Detecção Precoce de Câncer Limite: Humans Idioma: En Revista: Eur J Gastroenterol Hepatol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Detecção Precoce de Câncer Limite: Humans Idioma: En Revista: Eur J Gastroenterol Hepatol Ano de publicação: 2024 Tipo de documento: Article